Lack of association between a disease-susceptible single-nucleotide polymorphism, rs2230926 of TNFAIP3 , and tumour necrosis factor inhibitor therapeutic failure in Japanese patients with rheumatoid arthritis.

Authors :: Matsuoka H
Kabata D
Taura A
Matsui T
Takahi K
Hirano F
Katayama M
Okamoto A
Suenaga Y
Suematsu E
Yoshizawa S
Ohmura K
Ito S
Takaoka H
Oguro E
Kuzuya K
Okita Y
Udagawa C
Yoshimura M
Teshigawara S
Harada Y
Isoda K
Yoshida Y
Ohshima S
Tohma S
Saeki Y
Source :: Scandinavian journal of rheumatology [Scand J Rheumatol] 2020 May; Vol. 49 (3), pp. 253-255.
Publication Year :: 2020

Subjects :: Adalimumab therapeutic use
Adult
Aged
Antibodies, Monoclonal therapeutic use
Arthritis, Rheumatoid genetics
Asian People
Etanercept therapeutic use
Female
Humans
Infliximab therapeutic use
Japan
Male
Middle Aged
Polymorphism, Single Nucleotide
Prognosis
Treatment Failure
Arthritis, Rheumatoid drug therapy
Tumor Necrosis Factor Inhibitors therapeutic use
Tumor Necrosis Factor alpha-Induced Protein 3 genetics

Full Text Access

Tools